BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18267049)

  • 1. Rotavirus vaccines: how they work or don't work.
    Ward RL
    Expert Rev Mol Med; 2008 Feb; 10():e5. PubMed ID: 18267049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of potential protective mechanisms on the development of live rotavirus vaccines.
    Ward RL; Clark HF; Offit PA
    J Infect Dis; 2010 Sep; 202 Suppl():S72-9. PubMed ID: 20684721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model.
    Ward RL
    Viral Immunol; 2003; 16(1):17-24. PubMed ID: 12725685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice.
    McNeal MM; Basu M; Bean JA; Clements JD; Choi AH; Ward RL
    Virology; 2007 Jul; 363(2):410-8. PubMed ID: 17337285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of protection against rotavirus infection and disease.
    Ward R
    Pediatr Infect Dis J; 2009 Mar; 28(3 Suppl):S57-9. PubMed ID: 19252425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of serum antibodies in the protection against rotavirus disease: an overview.
    Jiang B; Gentsch JR; Glass RI
    Clin Infect Dis; 2002 May; 34(10):1351-61. PubMed ID: 11981731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus vaccines: recent developments and future considerations.
    Angel J; Franco MA; Greenberg HB
    Nat Rev Microbiol; 2007 Jul; 5(7):529-39. PubMed ID: 17571094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity and correlates of protection for rotavirus vaccines.
    Franco MA; Angel J; Greenberg HB
    Vaccine; 2006 Apr; 24(15):2718-31. PubMed ID: 16446014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal and systemic antibody responses and protection induced by a prime/boost rotavirus-DNA vaccine in a gnotobiotic pig model.
    Yuan L; Azevedo MS; Gonzalez AM; Jeong KI; Van Nguyen T; Lewis P; Iosef C; Herrmann JE; Saif LJ
    Vaccine; 2005 Jun; 23(30):3925-36. PubMed ID: 15917114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice.
    McNeal MM; Barone KS; Rae MN; Ward RL
    Virology; 1995 Dec; 214(2):387-97. PubMed ID: 8553539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.
    Dennehy M; Bourn W; Steele D; Williamson AL
    Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus disease and prevention through vaccination.
    Marshall GS
    Pediatr Infect Dis J; 2009 Apr; 28(4):355-62, quiz 363-4. PubMed ID: 19333083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine.
    Ward RL; Bernstein DI; Smith VE; Sander DS; Shaw A; Eiden JJ; Heaton P; Offit PA; Clark HF
    J Infect Dis; 2004 Jun; 189(12):2290-3. PubMed ID: 15181577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O; Cunliffe NA
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of candidate rotavirus vaccines derived from neonatal strains in India.
    Glass RI; Bhan MK; Ray P; Bahl R; Parashar UD; Greenberg H; Rao CD; Bhandari N; Maldonado Y; Ward RL; Bernstein DI; Gentsch JR
    J Infect Dis; 2005 Sep; 192 Suppl 1():S30-5. PubMed ID: 16088802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches in oral rotavirus vaccines.
    Kuate Defo Z; Lee B
    Crit Rev Microbiol; 2016 May; 42(3):495-505. PubMed ID: 25268934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural immunity to rotavirus infection in children.
    Malik J; Bhan MK; Ray P
    Indian J Biochem Biophys; 2008 Aug; 45(4):219-28. PubMed ID: 18788471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
    Jiang B; Gentsch JR; Glass RI
    Vaccine; 2008 Dec; 26(52):6754-8. PubMed ID: 18951937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS; Block SL
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to rotavirus infection in mice.
    Franco MA; Greenberg HB
    J Infect Dis; 1999 May; 179 Suppl 3():S466-9. PubMed ID: 10099121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.